Phytobisolvon complete 100 ml GR

Dénomination commerciale

Phytobisolvon complete 100 ml GR

08056300620877

805630062FTPR77A3

Numéro de référence/catalogue

FTPR77

GS1

Classe IIa

Législation applicable

MDR [Règlement (UE) 2017/745 relatif aux dispositifs médicaux]

Statut

Sur le marché

Quantité

1

Description complémentaire du produit

Phytobisolvon complete is a medical device composed of substances, not sterile, intended for short term invasive con-tact with respect to body orifices (oral cavity), designed for the treatment of dry and productive cough and sore throat in children (2+), adolescents and adults.

URL des informations complémentaires

https://labomar.com/en/products/ftpr77/

Dimensions cliniques

Aucune dimension clinique enregistrée pour ce dispositif.

Nomenclature européenne des dispositifs médicaux — la classification produit UE attribuée à ce dispositif.

• V9017ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES

1 avertissement enregistré — faire défiler le panneau pour tout voir.

• If you do not notice appreciable results after a short period of treatment (7 days), contact your doctor. Do not take it if you are allergic, intolerant or hypersensitive to any component. Do not administer the product to children under two years of age. Do not use the product after the expiry date printed on the package. Keep out of the reach of children. Do not use for purposes other than that for which the product is intended. No side effects associated by used the device have been observed. If you notice the appearance of side effects, inform your doctor. Expiry date refers to the product in its intact packaging, and properly stored. Since no data on use during pregnancy and lactation are available, its use is generally not recommended as a precaution due to lack of experimental data. Even if no side effects are known, it is recommended not to use the product during pregnancy or breastfeeding. In any case, consult your doctor before taking it. In the event of concomitant pharmacological treatment, although no interactions with drugs are known, it is advisable to consult a doctor before use. Do not exceed the recommended daily dose. Do not use in case the package is not intact. The period of validity after the first opening of the syrup is 24 weeks. Any serious incident that has occurred in relation to the device should be reported to the manufacturer and the Competent Autorithy. In case of any undesired event always seek for medical advice.

  AUTRE